Skip to main content
TipRanks
Go Ultimate75% OFF

TScan Therapeutics (TCRX) Drug Pipeline

430 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Control, Tsc-101Aml, MdsPhase IIIRecruitingA Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell TransplantationJul 01, 2026―
Tsc-204-A0201, Tsc-204-C0702, Tsc-200-A0201, Tsc-204-A0201 + Tsc-204-C0702, Tsc-204-A0201 + Tsc-200-A0201, Tsc-204-C0702 + Tsc-200-A0201, Tsc-204-A0201 + Tsc-203-A0201, Tsc-204-C0702 + Tsc-203-A0201, Tsc-200-A0201 + Tsc-203-A0201, Tsc-203-A0201, Tsc-204-A0101, Tsc-201-B0702, Tsc-204-A0201 + Tsc-204-A0101, Tsc-204-A0201 + Tsc-201-B0702, Tsc-204-C0702 + Tsc-204-A0101, Tsc-204-C0702 + Tsc-201-B0702, Tsc-200-A0201 + Tsc-204-A0101, Tsc-200-A0201 + Tsc-201-B0702, Tsc-203-A0201 + Tsc-204-A0101, Tsc-203-A0201 + Tsc-201-B0702, Tsc-202-A0201, Tsc-204-A0201 + Tsc-202-A0201, Tsc-204-C0702 + Tsc-202-A0201, Tsc-200-A0201 + Tsc-202-A0201, Tsc-203-A0201 + Tsc-202-A0201, Tsc-204-A0101 + Tsc-202-A0201, Tsc-201-B0702 + Tsc-202-A0201Cervical Cancer, Ovarian Cancer, Melanoma, Head And Neck Cancer, Hpv Positive Oropharyngeal Squamous Cell Carcinoma, Hpv-Related Cervical Carcinoma, Hpv-Related Carcinoma, Hpv-Related Anal Squamous Cell Carcinoma, Hpv-Related Penile Squamous Cell Carcinoma, Hpv-Related Vulvar Squamous Cell Carcinoma, Non-Small Cell Carcinoma, Hpv-Related Malignancy, Anogenital Cancers, Hpv - Anogenital Human Papilloma Virus Infection, Hpv-Related Squamous Cell Carcinoma, Hpv-Related Adenocarcinoma, Hpv-Related Adenosquamous Carcinoma, Hpv-Associated Vaginal Adenocarcinoma, Hpv-Related Endocervical Adenocarcinoma, Hpv-Related Verrucous Carcinoma, Hpv Positive Rectal Squamous Cell CarcinomaPhase IRecruitingA Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid TumorsJul 25, 2023
Control, Soc + Tsc-100, Soc + Tsc-101Myelodysplastic Syndromes, Aml, All, AdultPhase IRecruitingA Phase 1/3 Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation (ALLOHA-2)Jul 11, 2022

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Tscan Therapeutics, Inc. (TCRX) have in its pipeline
TScan Therapeutics TCRX is currently developing the following drugs: Control, Tsc-101, Tsc-204-A0201, Tsc-204-C0702, Tsc-200-A0201, Tsc-204-A0201 + Tsc-204-C0702, Tsc-204-A0201 + Tsc-200-A0201, Tsc-204-C0702 + Tsc-200-A0201, Tsc-204-A0201 + Tsc-203-A0201, Tsc-204-C0702 + Tsc-203-A0201, Tsc-200-A0201 + Tsc-203-A0201, Tsc-203-A0201, Tsc-204-A0101, Tsc-201-B0702, Tsc-204-A0201 + Tsc-204-A0101, Tsc-204-A0201 + Tsc-201-B0702, Tsc-204-C0702 + Tsc-204-A0101, Tsc-204-C0702 + Tsc-201-B0702, Tsc-200-A0201 + Tsc-204-A0101, Tsc-200-A0201 + Tsc-201-B0702, Tsc-203-A0201 + Tsc-204-A0101, Tsc-203-A0201 + Tsc-201-B0702, Tsc-202-A0201, Tsc-204-A0201 + Tsc-202-A0201, Tsc-204-C0702 + Tsc-202-A0201, Tsc-200-A0201 + Tsc-202-A0201, Tsc-203-A0201 + Tsc-202-A0201, Tsc-204-A0101 + Tsc-202-A0201, Tsc-201-B0702 + Tsc-202-A0201, Control, Soc + Tsc-100, Soc + Tsc-101. These drug candidates are in various stages of clinical development as the company works toward FDA approval.